Graphene as Photothermal Therapeutic Agents

Adv Exp Med Biol. 2022:1351:177-200. doi: 10.1007/978-981-16-4923-3_9.

Abstract

Light-assisted hyperthermic therapy is a promising strategy to treat cancer. Graphene and their derivatives with unique physiochemical properties, intrinsic near infrared absorption, and ability to transduce the absorbed light energy into heat, have attracted researchers to use them for photothermal therapy (PTT). In addition, the presence of surface functional groups and large surface area that can facilitate interactions with hydrophobic molecules has favored the use of graphene allotropes for developing PTT-based combinatorial therapies. In this book chapter we have reviewed different graphene-based PTT-assisted photodynamic, gene, chemo, and immunotherapeutic strategies developed to improve the outcome of cancer treatment. We have also discussed how PTT from graphene derivatives can improve the therapeutic outcomes of gene, chemo, and immunotherapies. Finally, this book chapter provides promising insights to develop novel graphene-based multifunctional PTT-assisted combinatorial therapeutics with both imaging and therapeutic regimens to treat cancer.

Keywords: Bioimaging; Combined photothermal therapy; Graphene photothermal therapy; Theranostics.

MeSH terms

  • Graphite* / chemistry
  • Humans
  • Hyperthermia, Induced*
  • Neoplasms* / drug therapy
  • Photochemotherapy* / methods
  • Phototherapy

Substances

  • Graphite